HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Prothrombin Complex Concentrates in Pediatric Cardiac Surgery: The Current State and the Future.

AbstractBACKGROUND:
After decades of practice of pediatric cardiac surgery, postoperative bleeding due to the immaturity of hemostasis, hemodilution, and hypothermia remains a concern. Recently, a new approach for adult coagulopathy after bypass has emerged. Prothrombin complex concentrates (PCCs), designed to treat bleeding in hemophilia patients, are safely and efficiently used off label for hemorrhage after bypass. However, optimal dosing, indications and contraindications, and laboratory tests to assess the efficacy of PCC use in children have not yet been established. This literature review outlines the challenges of bypass-related coagulopathy, the pharmacology, and the experience in use of PCCs, with a focus on their potential in pediatric cardiac surgery.
METHODS:
After a thorough literature search of MEDLINE, Scopus, and Ovid databases using the term "prothrombin complex concentrate AND pediatric," 23 relevant articles were selected.
RESULTS:
The data supporting successful use of PCCs in acquired coagulopathy after cardiac surgery in adults have been increasing. Although small volume, low immunogenicity, efficiency, and speed in correcting coagulopathy are attractive qualities of PCCs for pediatric practice, current evidence is only anecdotal. The main concerns are unknown dosing regimens, the inability to closely monitor the effects of PCCs in real time, and a possibility of thrombotic complications, which can be particularly devastating in young congenital cardiac patients whose lives frequently depend upon the patency of artificial shunts.
CONCLUSIONS:
Extensive, high-quality research is warranted to fill in the gaps of knowledge regarding using PCCs in pediatric cardiac practice.
AuthorsElena Ashikhmina, Sameh Said, Mark M Smith, Vilmarie Rodriguez, William C Oliver Jr, Gregory A Nuttall, Joseph A Dearani, Hartzell V Schaff
JournalThe Annals of thoracic surgery (Ann Thorac Surg) Vol. 104 Issue 4 Pg. 1423-1431 (Oct 2017) ISSN: 1552-6259 [Electronic] Netherlands
PMID28648539 (Publication Type: Journal Article, Review)
CopyrightCopyright © 2017 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.
Chemical References
  • Blood Coagulation Factors
  • Hemostatics
  • prothrombin complex concentrates
Topics
  • Blood Coagulation Factors (pharmacology, therapeutic use)
  • Cardiac Surgical Procedures
  • Child
  • Contraindications
  • Hemostasis (drug effects)
  • Hemostatics (pharmacology, therapeutic use)
  • Humans
  • Pediatrics
  • Postoperative Hemorrhage (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: